Trial Profile
Atorvastatin Action on Oxidative Stress and Inflammation in Type II Diabetes: The HDL Particle Protection Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HDL PROTECT
- 30 Jan 2018 Status changed from recruiting to completed.
- 02 Jul 2014 New trial record